razoxane has been researched along with Leukemia, Myeloid, Acute in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (55.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallegos-Castorena, S; Gonzalez-Ramella, O; Sánchez-Medina, J | 1 |
| Anderson, P; Chandra, J; Fulbright, JM; Huh, W | 1 |
| Asselin, BL; Athale, UH; Clavell, L; Cohen, HJ; Cole, PD; Kelly, KM; Larsen, EC; Laverdière, C; Lipshultz, SE; Michon, B; Neuberg, DS; Sallan, SE; Schorin, M; Schwartz, CL; Silverman, LB; Stevenson, KE; Vrooman, LM | 1 |
| Aplenc, R; Fisher, BT; Huang, YS; Li, Y; Seif, AE; Torp, K; Walker, DM | 1 |
| Lipshultz, SE; Lipsitz, SR; Orav, EJ | 1 |
| Barrett, AJ; Joshi, R; Phillips, RH; Smith, B | 1 |
| Creighton, AM | 1 |
| Griffiths, WA; Levene, GM; Steinman, HK | 1 |
| Davidson, RN; Hiwaizi, F; Lakhani, S; Marsden, RA | 1 |
| Caffrey, EA; Clark, KG; Daker, MG; Horton, JJ; MacDonald, DM; Wells, RS | 1 |
| Gao, LS; Wang, XY; Zhang, MH | 1 |
| Lemez, P; Maresová, J | 1 |
| DiSalle, M; Lifton, R; Woodlock, TJ | 1 |
| Bhavnani, M; Delamore, IW; Dhir, K | 1 |
| Shaw, D; Tudhope, GR | 1 |
| Guo, Y; Lin, B; Lu, D; Xue, Y | 1 |
| Bhavnani, M; Wolstenholme, RJ | 1 |
| Caffrey, EA; Daker, MG; Horton, JJ | 1 |
| Griffiths, WA | 1 |
1 review(s) available for razoxane and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Can anthracycline therapy for pediatric malignancies be less cardiotoxic?
Topics: Adolescent; Adult; Anthracyclines; Child; Delayed-Action Preparations; Disease Progression; Doxorubicin; Drug Administration Schedule; Drug Carriers; Drug Dosage Calculations; Drug-Related Side Effects and Adverse Reactions; Heart; Heart Diseases; Heart Failure; Humans; Iron Chelating Agents; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Razoxane; Risk Factors; Treatment Outcome | 2010 |
1 trial(s) available for razoxane and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Efficacy of dexrazoxane as a cardioprotective agent in patients receiving mitoxantrone- and daunorubicin-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Agents; Daunorubicin; Female; Heart Diseases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Razoxane | 1998 |
18 other study(ies) available for razoxane and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
The effect of dexrazoxane for clinical and subclinical cardiotoxicity in children with acute myeloid leukemia.
Topics: Adolescent; Anthracyclines; Cardiovascular Agents; Child; Child, Preschool; Female; Follow-Up Studies; Heart Diseases; Humans; Infant; Leukemia, Myeloid, Acute; Male; Prospective Studies; Razoxane; Survival Rate; Treatment Outcome | 2010 |
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.
Topics: Adolescent; Antineoplastic Agents; Cardiotonic Agents; Child; Child, Preschool; Female; Humans; Incidence; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Risk; Time Factors | 2011 |
Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems database.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cohort Studies; Databases, Factual; Female; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Retrospective Studies; Young Adult | 2013 |
Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidence.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasms, Second Primary; Randomized Controlled Trials as Topic; Razoxane; Risk Assessment; Scientific Misconduct; Sensitivity and Specificity; Survival Rate | 2007 |
Acute myelomonocytic leukaemia after razoxane therapy.
Topics: Female; Gastrointestinal Neoplasms; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Piperazines; Razoxane | 1981 |
Leukaemia associated with razoxane.
Topics: Humans; Leukemia, Myeloid, Acute; Piperazines; Razoxane | 1982 |
Methotrexate in lieu of razoxane for incapacitating psoriasis.
Topics: Humans; Leukemia, Myeloid, Acute; Methotrexate; Piperazines; Psoriasis; Razoxane; Skin Neoplasms | 1984 |
Razoxane and leukaemia.
Topics: Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Piperazines; Razoxane | 1984 |
Leukaemia in psoriatic patients treated with razoxane.
Topics: Humans; Leukemia, Myeloid, Acute; Piperazines; Psoriasis; Razoxane | 1984 |
[140 cases of acute leukemia caused by bimolane].
Topics: Adult; Aged; Female; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Psoriasis; Razoxane; Retrospective Studies | 1993 |
Coincident acute myelogenous leukemia and ischemic heart disease: use of the cardioprotectant dexrazoxane during induction chemotherapy.
Topics: Adult; Aged; Cardiovascular Agents; Humans; Leukemia, Myeloid, Acute; Male; Myocardial Ischemia; Razoxane | 1998 |
Razoxane in treatment of acute myeloid leukaemia.
Topics: Adolescent; Adult; Aged; Humans; Leukemia, Myeloid, Acute; Middle Aged; Piperazines; Razoxane; Remission, Spontaneous | 1978 |
Razoxane in treatment of acute myeloid leukaemia.
Topics: Adolescent; Adult; Aged; Cytarabine; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Middle Aged; Piperazines; Razoxane; Remission, Spontaneous | 1978 |
Razoxane in treatment of acute myeloid leukaemia.
Topics: Cytarabine; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Piperazines; Razoxane | 1978 |
Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis.
Topics: Adolescent; Adult; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Psoriasis; Razoxane; Translocation, Genetic; Treatment Outcome | 1992 |
Razoxane and acute promyelocytic leukaemia.
Topics: Aged; Female; Humans; Leukemia, Myeloid, Acute; Piperazines; Razoxane | 1987 |
Acute myeloid leukaemia after treatment with razoxane.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Piperazines; Prospective Studies; Psoriasis; Razoxane | 1985 |
Risk of leukemia associated with chemotherapy.
Topics: Humans; Leukemia, Myeloid, Acute; Male; Piperazines; Psoriasis; Razoxane; Risk | 1985 |